Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
Skyrizi is a brand-name prescription medication FDA-approved to treat moderate-to-severe plaque psoriasis, active psoriatic arthritis, active Crohns disease, and active ulcerative colitis
The agreement was never formally extended, but NDC has continued paying $5.5 million annually, a price unadjusted since execution
Metabolism refers to the processes your body uses to convert food into energy
What are the assets the companies are vying for, and how do they stack up against other contenders in the obesity drug market
Our team will work with you to develop a personalized plan tailored to your needs
US$ 29.23
US$ 20.65
US$ 27.98
US$ 23.64
US$ 24.04
US$ 21.03
